DrugPatentWatch Database Preview
Drugs in Development Information for Camptothecin
Email this page to a colleague
What is the drug development status for Camptothecin?
Camptothecin is an investigational drug.
There have been 99 clinical trials for Camptothecin.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 1998.
The most common disease conditions in clinical trials are Lung Neoplasms, Small Cell Lung Carcinoma, and Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Astex Pharmaceuticals, and University of New Mexico.
Summary for Camptothecin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,685 |
| WIPO Patent Applications | 2,393 |
| Japanese Patent Applications | 187 |
| Clinical Trial Progress | Phase 2 (1998-11-01) |
| Vendors | 87 |
Recent Clinical Trials for Camptothecin
| Title | Sponsor | Phase |
|---|---|---|
| A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors | National Cancer Institute (NCI) | Phase 1/Phase 2 |
| How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix | Assiut University | Phase 2 |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy in Advanced or Metastatic Cancers of the Stomach and Intestines | National Cancer Institute (NCI) | Phase 1 |
Clinical Trial Summary for Camptothecin
Top disease conditions for Camptothecin
Top clinical trial sponsors for Camptothecin
US Patents for Camptothecin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
